| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |